1. S318 Optimized Lower Dose Combinations of Sulindac Plus Erlotinib Sustained Antitumor Efficacy and Reduced Toxicity in a Preclinical Model of FAP. (October 2021) Authors: Demirhan, Yunus Emre; Rajendran, Praveen; Dashwood, Wan-Mohaiza; Kapoor, Sabeeta; Ulusan, Ahmet; Tripathi, Chakrapani; Demirhan, Melek; Shapiro, Alessandro; Savage, Michelle; Brown, Powel; Sei, Shizuko; Mohammed, Altaf; Sanchez, Eduardo Vilar; Dashwood, Roderick Journal: American journal of gastroenterology Issue: Volume 116:Supplement(2021)ACG Annual Meeting Abstracts 1 Page Start: S138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗